Elekta announced today that its Evo CT Linac received FDA 510(k) clearance, making it available to U.S. radiation oncology ...

CET, hosts its Strategic Update for investors, providing an overview of the company's strategic direction and ongoing transformation. The event, led by CEO ...

Capital Markets Day presentations highlight opportunities and potential based on Elekta's strong position STOCKHOLM, June 7, 2021 /PRNewswire/ -- At Elekta's (EKTA-B.ST) Capital Markets Day, CEO, ...

Elekta EKTAY recently announced that its Elekta Evo CT-Linac has received 510(k) clearance from the FDA, making the system ...

CRAWLEY, United Kingdom, Sept. 5, 2019 /PRNewswire/ -- Elekta (EKTA-B.ST) has signed a distribution agreement with DOSIsoft, a company that offers patient-specific quality assurance (QA) software, to ...

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Elekta CEO Gustaf Salford will leave the company after the ...

STOCKHOLM, Nov. 26, 2020 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that Gustaf Salford has been appointed to the role of President and CEO, effective immediately. He has been Acting CEO since ...

Investing.com - Elekta (BS:EKTABs) AB shares plunged 10.25% after the Swedish medical equipment maker lowered its full-year guidance, citing weaker sales expectations in China and the United States.

Swedish radiation therapy equipment company Elekta has acquired Sanford, Florida-based company ProKnow to gain its treatment planning and data analytics capabilities, per an announcement Thursday.

STOCKHOLM, June 7, 2021 /PRNewswire/ -- At Elekta's (EKTA-B.ST) Capital Markets Day, CEO, Gustaf Salford, and members from his executive management team introduced the company's mid-term strategy, ...